670P Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC)

Autor: Luginbuhl, A., Scott, E., Harshyne, L., Flerova, E., Tuluc, M., Gargano, S., Curry, J.M., Cognetti, D., Argiris, A., Johnson, J.M.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S849-S849
Databáze: ScienceDirect